Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Xanthogranuloma”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Testing effectiveness (Phase 2)Looking for participantsNCT06153173
What this trial is testing

Mirdametinib in Histiocytic Disorders

Who this might be right for
Langerhans Cell Histiocytosis (LCH)Juvenile Xanthogranuloma (JXG)Rosai-Dorfman Disease (RDD)+1 more
Children's Hospital Medical Center, Cincinnati 40
Not applicableLooking for participantsNCT04158284
What this trial is testing

Multicenter Registry for Patients With Childhood.Onset Craniopharyngioma, Xanthogranuloma, Cysts of Rathke's Pouch, Meningioma, Pituitary Adenoma, Arachnoid Cysts

Who this might be right for
CraniopharyngiomaObesity
Klinikum Oldenburg gGmbH 90
Not applicableNot Yet RecruitingNCT07173010
What this trial is testing

Pediatric Arthropathy Beyond Inflammation: Clinical Spectrum and Diagnostic Approach at Assiut University Children Hospital

Who this might be right for
MucopolysaccharidosesProgressive Pseudorheumatoid DysplasiaFarber Disease+3 more
Assiut University 35
Not applicableLooking for participantsNCT05915208
What this trial is testing

Histiocytic Disorder Follow-up Study

Who this might be right for
HistiocytosisLangerhans Cell HistiocytosisErdheim-Chester Disease+3 more
University of Alabama at Birmingham 6,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT03155620
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+42 more
National Cancer Institute (NCI) 1,376
Testing effectiveness (Phase 2)Looking for participantsNCT04079179
What this trial is testing

Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders

Who this might be right for
Langerhan's Cell HistiocytosisJuvenile XanthogranulomaErdheim-Chester Disease+4 more
Carl Allen 90
Not applicableWithdrawnNCT02298634
What this trial is testing

Biomarker for Farber Disease (BioFarber)

Who this might be right for
Farber's LipogranulomatosisCeramidase DeficiencyHepatomegaly+1 more
CENTOGENE GmbH Rostock
Not applicableStudy completedNCT03233841
What this trial is testing

Farber Disease Natural History Study

Who this might be right for
Farber DiseaseFarber's DiseaseFarber Lipogranulomatosis+4 more
Sumitomo Pharma Switzerland GmbH 45
Not applicableLooking for participantsNCT02285582
What this trial is testing

International Rare Histiocytic Disorders Registry (IRHDR)

Who this might be right for
Rare Histiocytic Disorders (RHDs)Erdheim-Chester Disease (ECD)Rosai-Dorfman Disease (RDD)+7 more
The Hospital for Sick Children 400